{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:24:06Z","timestamp":1791433446495,"version":"4.3.3"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asian J Androl"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4103\/1008-682x.131064","type":"journal-article","created":{"date-parts":[[2014,4,19]],"date-time":"2014-04-19T03:08:58Z","timestamp":1397876938000},"page":"735","source":"Crossref","is-referenced-by-count":22,"title":["Chronic bacterial prostatitis and irritable bowel syndrome: effectiveness of treatment with rifaximin followed by the probiotic VSL#3"],"prefix":"10.4103","volume":"16","author":[{"given":"Sandro","family":"La Vignera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Vicari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Castiglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RositaA","family":"Condorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LuciaO","family":"Vicari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AldoE","family":"Calogero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1008-682X.131064-1","first-page":"1333","volume-title":"Prevalence of and risk factors for prostatitis: population based assessment using physician assigned diagnoses","author":"Clemens","year":"2007","journal-title":"J Urol"},{"key":"key-10.4103\/1008-682X.131064-2","first-page":"737","volume-title":"Prostatitis: evolving management strategies","author":"Nickel","year":"1999","journal-title":"Urol Clin North Am"},{"key":"key-10.4103\/1008-682X.131064-3","first-page":"2234","volume-title":"Pseudodyssynergia (contraction of the external sphincter during voiding) misdiagnosed as chronic nonbacterial prostatitis and the role of biofeedback as a therapeutic option","author":"Kaplan","year":"1997","journal-title":"J Urol"},{"key":"key-10.4103\/1008-682X.131064-4","first-page":"e330","volume-title":"Male accessory gland infection and sperm parameters (review)","author":"La","year":"2011","journal-title":"Int J Androl"},{"key":"key-10.4103\/1008-682X.131064-5","first-page":"2123","volume-title":"Evidence for overlap between urological and nonurological unexplained clinical conditions","author":"Rodr\u00edguez","year":"2009","journal-title":"J Urol"},{"key":"key-10.4103\/1008-682X.131064-6","first-page":"2108","volume-title":"AGA technical review on irritable bowel syndrome","author":"Drossman","year":"2002","journal-title":"Gastroenterology"},{"key":"key-10.4103\/1008-682X.131064-7","first-page":"338","volume-title":"[Investigation of chronic prostatitis and altered bowel habits]","author":"Li","year":"2002","journal-title":"Zhonghua Nan Ke Xue"},{"key":"key-10.4103\/1008-682X.131064-8","first-page":"e18647","volume-title":"High frequency of chronic bacterial and non-inflammatory prostatitis in infertile patients with prostatitis syndrome plus irritable bowel syndrome","author":"Vicari","year":"2011","journal-title":"PLoS One"},{"key":"key-10.4103\/1008-682X.131064-9","first-page":"183","volume-title":"Male accessory gland infection frequency in infertile patients with chronic microbial prostatitis and irritable bowel syndrome","author":"Vicari","year":"2012","journal-title":"Int J Androl"},{"key":"key-10.4103\/1008-682X.131064-10","first-page":"375","volume-title":"Irritable bowel syndrome: the role of the intestinal microbiota, pathogenesis and therapeutic targets","author":"Dahlqvist","year":"2011","journal-title":"Acta Gastroenterol Belg"},{"key":"key-10.4103\/1008-682X.131064-11","first-page":"264","volume-title":"Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy","author":"Camilleri","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"key-10.4103\/1008-682X.131064-12","first-page":"403","volume-title":"Review article: probiotics for the treatment of irritable bowel syndrome - focus on lactic acid bacteria","author":"Clarke","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/1008-682X.131064-13","first-page":"220","volume-title":"The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial","author":"Ki","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"key-10.4103\/1008-682X.131064-14","first-page":"294","volume-title":"Bacterial supplementation in the irritable bowel syndrome.A randomised double-blind placebo-controlled crossover study","author":"O\u2032Sullivan","year":"2000","journal-title":"Dig Liver Dis"},{"key":"key-10.4103\/1008-682X.131064-15","first-page":"2615","volume-title":"Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome","author":"Sen","year":"2002","journal-title":"Dig Dis Sci"},{"key":"key-10.4103\/1008-682X.131064-16","first-page":"5826","volume-title":"Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin","author":"Weinstock","year":"2011","journal-title":"Can J Urol"},{"key":"key-10.4103\/1008-682X.131064-17","first-page":"1480","volume-title":"Functional bowel disorders","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"key-10.4103\/1008-682X.131064-18","first-page":"70","volume-title":"Gender role in irritable bowel syndrome: a comparison of irritable bowel syndrome module (ROME III) between male and female patients","author":"Anbardan","year":"2012","journal-title":"J Neurogastroenterol Motil"},{"key":"key-10.4103\/1008-682X.131064-19","first-page":"19","volume-title":"Enhancing detection of gonococcus in ejaculates of adult males using sperm dilution","author":"Vicari","year":"1986","journal-title":"Arch Androl"},{"key":"key-10.4103\/1008-682X.131064-20","first-page":"2536","volume-title":"Effectiveness and limits of antimicrobial treatment on seminal leukocyte concentration and related reactive oxygen species production in patients with male accessory gland infection","author":"Vicari","year":"2000","journal-title":"Hum Reprod"},{"key":"key-10.4103\/1008-682X.131064-21","first-page":"2025","volume-title":"Seminal leukocyte concentration and related specific reactive oxygen species production in patients with male accessory gland infections","author":"Vicari","year":"1999","journal-title":"Hum Reprod"},{"key":"key-10.4103\/1008-682X.131064-22","unstructured":"World Health Organization. WHO Laboratory Manual for the Examination of the Human Semen and Sperm-Cervical Mucus Interaction. 4 th ed. Cambridge: Cambridge University Press; 1999."},{"key":"key-10.4103\/1008-682X.131064-23","first-page":"II43","volume-title":"Functional bowel disorders and functional abdominal pain","author":"Thompson","year":"1999","journal-title":"Gut"},{"key":"key-10.4103\/1008-682X.131064-24","first-page":"15","volume-title":"A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome","author":"Hoveyda","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"key-10.4103\/1008-682X.131064-25","first-page":"325","volume-title":"The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review","author":"Moayyedi","year":"2010","journal-title":"Gut"},{"key":"key-10.4103\/1008-682X.131064-26","first-page":"252","volume-title":"Irritable bowel syndrome, gut microbiota and probiotics","author":"Lee","year":"2011","journal-title":"J Neurogastroenterol Motil"},{"key":"key-10.4103\/1008-682X.131064-27","first-page":"1033","volume-title":"The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review","author":"Brenner","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"key-10.4103\/1008-682X.131064-28","first-page":"212","volume-title":"Probiotics in the management of irritable bowel syndrome: a review of clinical trials","author":"Hamilton-Miller","year":"2001","journal-title":"Microb Ecol Health Dis"},{"key":"key-10.4103\/1008-682X.131064-29","first-page":"895","volume-title":"A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome","author":"Kim","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/1008-682X.131064-30","first-page":"1143","volume-title":"A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome","author":"Niedzielin","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key-10.4103\/1008-682X.131064-31","first-page":"541","volume-title":"Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles","author":"O\u2032Mahony","year":"2005","journal-title":"Gastroenterology"},{"key":"key-10.4103\/1008-682X.131064-32","first-page":"408","volume-title":"Rifaximin treatment for symptoms of irritable bowel syndrome","author":"Fumi","year":"2008","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/1008-682X.131064-33","first-page":"455","volume-title":"Antibiotics for the treatment of irritable bowel syndrome","author":"Basseri","year":"2011","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"key-10.4103\/1008-682X.131064-34","first-page":"22","volume-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation","author":"Pimentel","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1008-682X.131064-35","first-page":"28","volume-title":"The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis","author":"Menees","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"key-10.4103\/1008-682X.131064-36","first-page":"415","volume-title":"Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome","author":"Hong","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"key-10.4103\/1008-682X.131064-37","first-page":"288","volume-title":"The probiotic approach: an alternative treatment option in urology","author":"Hoesl","year":"2005","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.131064-38","first-page":"490","volume-title":"Effect of a probiotic preparation (VSL#3) in critically ill patients: a randomized, double-blind, placebo-controlled trial (Pilot Study)","author":"Ebrahimi-Mameghani","year":"2013","journal-title":"Pak J Med Sci"}],"container-title":["Asian Journal of Andrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:22:27Z","timestamp":1786648947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1008-682X.131064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"alternative-id":["131064"],"URL":"https:\/\/doi.org\/10.4103\/1008-682x.131064","relation":{},"ISSN":["1008-682X"],"issn-type":[{"value":"1008-682X","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}